Diskusjon Triggere Porteføljer Aksjonærlister

Targovax (TRVX) Småprat

Biotek
#10702

Ikke rare volumet, men ingen dupp i sluttauksjonen :+1:t3: Er trenden snudd nå? 5,39% opp uten børsmelding er uansett digg :ok_hand:t2:

1 Like
#10703

Nått bæd. Bare 100% opp til GA her da :ok_hand::chart_with_downwards_trend:

#10704

H.C. Wainwright Reiterates Buy Rating on Targovax AS

https://www.streetinsider.com/Intl+Ratings/H.C.+Wainwright+Reiterates+Buy+Rating+on+Targovax+AS+(TRVX%3ANO)/16147714.html

Samme mål som før; 19

11 Likes
Targovax - Småprat 2020 (TRVX)
#10705

Lenge siden jeg har kjøpt TRVX, men fylte på med litt mer i dag. Har en god magesårfølelse på TRVX nå👍

6 Likes
#10706

TARGOVAX (Norsk Bulls)

Last Signal: STAY LONG

Signal Update
Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 14.11.2019, 4 days ago, when the stock price was 5.0400. Since then TRVX.OL has risen by +4.76%.

Market Outlook
The bulls are in full control. The negative sentiment that caused the bearish stop loss to be triggered has evaporated. Besides, the signal is suggesting to STAY LONG. It is best to follow the signal and continue to STAY LONG.

2 Likes
#10707

Er det ikke en emisjon på trappene i targo?

#10708

Etter kontantbeholdningen å dømme, ja…
Men penger kan komme inn flere veier…

#10709

image
image1281×365 18.7 KB

ref: https://clinicaltrials.gov/ct2/show/record/NCT02963831?term=ONCOS-102&draw=1&rank=3

Litt moro er det jo at de har endret secondary outcome measures i mars19 til ORR up to 15 months.
Ikke sikkert det betyr noe, men atleast 4 weeks er mye mindre.

6 Likes
#10710

Og completion juli 2020, her går det unna!

image
image832×79 5.54 KB

5 Likes
#10711

Bra med potensielle triggere i Targovax i 2020!

  • Readout malonoma 1H 2020

  • Readout Advanced Peritoneal Malignancies 2H 2020

  • Partner og oppstart av pivotal studie i mesothelioma

  • Partner på nye virus

1 Like
#10713

Ble vel lagt ut her i går… :stuck_out_tongue_winking_eye:

#10714

Targovax: Oncolytic adenovirus armed w immune stimulating transgene targeting basket of I-O indications. Strong results from Part 1 (ONCOS-102/Keytruda combo) trial in anti-PD1 refractory melanoma: 33% ORR in 9 pts: 1 CR, 2 PRs; immune act. in all 9 pts. Upcoming milestones: randomized data, Ph 1b/2 (mesothelioma, n=31) w/chemo: Jan 2020; Ph 1, Part 2 data (melanoma comb w/Keytruda, n=21): 1H2020; updates from collab partners in peritoneal metastasis & prostate exp 2020

1 Like
#10715

og ned 5 %

3 Likes
#10716

Tydelig at en i gaar bestemte seg for aa redusere. Saa lenge han ikke er ferdig forblir Targo en jojo.

#10717

6 Likes
#10718

Ny Radium:

https://soundcloud.com/user-972208711/episode-102

Hovedtema er Ultimovacs

#10719

Dagens :smiley:

1 Like
#10720

Nobel Prize-winning researcher

Immunterapi kommer til å fortsette å vokse.

image

3 Likes
#10721

Han er i Norge nå as we speak, ref. Radium.

#10722

Noe om TRVX i den nye episoden?